Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
about
Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in miceBeneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathwayEndothelial glucocorticoid receptor is required for protection against sepsis.Inhibition of tissue factor expression in brain microvascular endothelial cells by nanoparticles loading NF-kappaB decoy oligonucleotides.Possible role for anisodamine in organophosphate poisoning.Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.Modeling natural anti-inflammatory compounds by molecular topology.Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.Penehyclidine prevents nuclear factor-kappaB activation in acute lung injury induced by lipopolysaccharide.
P2860
Q34915674-C11CB29C-25E1-42A9-B79D-15EC5FE06909Q35025849-9B3DCF11-525B-4DEE-B52D-87811463605EQ36512205-90CF8B8C-CEBB-414D-BBD3-EB615128551AQ37083517-CBEBA49E-0182-4107-8179-601FBD922DC1Q38787139-3A2D4962-DDFB-442A-9134-0C00727DFA4EQ39107051-5D691A67-9768-4EC5-9273-FF78CE6645C9Q40362238-5FD3EE89-41A0-4A0F-AD18-2B98C4C4AD26Q42705126-A6F8F7AA-A47E-4202-B394-069C355C6726Q46418369-18D6CDB2-F6F2-44EB-8A1D-2C66F20EB930
P2860
Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@ast
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@en
type
label
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@ast
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@en
prefLabel
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@ast
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@en
P2093
P356
P1476
Anisodamine counteracts lipopo ...... ion of the NF-kappa b pathway.
@en
P2093
P356
10.1159/000051025
P50
P577
2001-01-01T00:00:00Z